Paragon Bioservices

Paragon Bioservices

Date of Investment: 2014
Status: Acquired by Catalent, Inc. (NYSE: CTLT) in 2019
Headquarters: Baltimore, Maryland
Paragon Bioservices is a contract development and manufacturing organization (CDMO) focused on gene therapies delivered via adeno-associated virus (AAV) vectors, as well as next generation vaccines, oncology immunotherapies and other complex biologics.
Visit: www.catalent.com